New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a specialized oncology-focused contract research organization (CRO), in a move aimed at ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine ...

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support future clinical programsGelrinC is set to transform cartilage repair market with ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of ...

"ICVAX is built on the innovative PD-1-Enhanced DNA vaccine technology invented and developed locally at the HKU," said Professor Zhiwei CHEN. "This study will help optimize delivery of ICVAX, paving ...

Discover Manthan 2026, a premier symposium by VASUs Foundation aimed at elevating India's role in life sciences research and ...

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa using AAV-based delivery. The trial is a collaboration with Cleveland Clinic ...

Acquisition adds further specialist biostatistics, data management, and medical writing expertise to Evestia Clinical's full-service offering and strengthens its presence in Germany and across Europe ...

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...